Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Cash & Equivalents: 2009-2024

Historic Cash & Equivalents for National Research (NRC) over the last 16 years, with FY2024 value amounting to $4.2 million.

  • National Research's Cash & Equivalents fell 3588.56% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 3588.56%. This contributed to the annual value of $4.2 million for FY2024, which is 3637.46% down from last year.
  • Latest data reveals that National Research reported Cash & Equivalents of $4.2 million as of FY2024, which was down 3637.46% from $6.7 million recorded in FY2023.
  • In the past 5 years, National Research's Cash & Equivalents ranged from a high of $54.4 million in FY2021 and a low of $4.2 million during FY2024
  • For the 5-year period, National Research's Cash & Equivalents averaged around $25.0 million, with its median value being $25.0 million (2022).
  • Its Cash & Equivalents has fluctuated over the past 5 years, first skyrocketed by 15663.98% in 2020, then plummeted by 7341.56% in 2023.
  • National Research's Cash & Equivalents (Annual) stood at $34.7 million in 2020, then surged by 56.71% to $54.4 million in 2021, then crashed by 53.96% to $25.0 million in 2022, then plummeted by 73.42% to $6.7 million in 2023, then crashed by 36.37% to $4.2 million in 2024.
  • Its Cash & Equivalents stands at $4.2 million for FY2024, versus $6.7 million for FY2023 and $25.0 million for FY2022.